1-4 of 4
Steve Hughes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Transmembrane Protease, Serine 6 (TMPRSS6) Antisense Oligonucleotide (IONIS-TMPRSS6-L RX ) Reduces Plasma Iron Levels of Healthy Volunteers in a Phase 1 Clinical Study

Michael McCaleb, PhD, Jason Lickliter, MBBS, PhD, Andrew Dibble, PhD, Eugene Schneider, MD, Mariam Aghajan, Shuling Guo, Steve Hughes, MD MBA, Richard S Geary, PhD, Brett P. Monia, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3634.
https://doi.org/10.1182/blood-2018-99-115339
Published: 2018
Journal Articles

Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia

Clinical Trials & Observations
John C. Byrd, Thomas J. Kipps, Ian W. Flinn, Januaro Castro, Thomas S. Lin, William Wierda, Nyla Heerema, James Woodworth, Steve Hughes, Shabnam Tangri, Sarah Harris, Dee Wynne, Arturo Molina, Bryan Leigh, Susan O'Brien
Journal: Blood
Blood (2010) 115 (3): 489–495.
https://doi.org/10.1182/blood-2009-08-237727
Published: 2010
Journal Articles

Lumiliximab Triggers Apoptosis Mechanisms in CLL Cells through the Inhibition of PI3-K/Akt Pathway.

Medhat Shehata, Susanne Schnabl, Elena Ponath, Stefanie Tauber, Dita Demirtas, Martin Hilgarth, Martin Bilban, Sigrun Badrnya, Karin Fleiss, Josef D. Schwarzmeier, Alexander Gaiger, Rainer Hubmann, Christoph C Zielinski, Steve Hughes, Ann Maclaren, Ulrich Jaeger
Journal: Blood
Blood (2009) 114 (22): 2371.
https://doi.org/10.1182/blood.V114.22.2371.2371
Published: 2009
Journal Articles

Anti-Drug Antibody Responses to Lumiliximab Are Not Detected in Relapsed Refractory CLL Patients Treated with Lumiliximab in Combination with FCR in a Phase 1/II Study

Julie Ranuio, Annalee Estrellado, Sarah Harris, Megan Shannon, Meena Subramanyam, Steve Hughes, James Woodworth, Shabnam Tangri
Journal: Blood
Blood (2008) 112 (11): 4210.
https://doi.org/10.1182/blood.V112.11.4210.4210
Published: 2008